Social Justice The Little Pink Pill That Sparked a Feminist War The Food and Drug Administration's approval of a pharmaceutical treatment for low sexual desire in women has launched a heated debate over the dangers and benefits of medicalizing sex. Maya Dusenbery
Social Justice Was Sexism Really Responsible for the FDA’s Hesitancy to Sign Off on Flibanserin? An early look at a Pacific Standard story that's currently only available to subscribers. Pacific Standard Staff
Social Justice Five Studies: Does Flibanserin Provide Real Sexual Benefits for Women? Research suggests that the now-FDA-approved female libido-booster is—at least in part—a pharmaceutical ploy. Anne Skomorowsky
Social Justice The Crazy History of Uterine Fury People have been afraid of vaginas for a very long time. Kate Wheeling
Social Justice ‘Pink Viagra’ Boon or Bust for Equal Rights? While pharmaceutical companies battle to end desire discrepancy, some feminists fear the medicalization of not being in the mood. Matt Smith